000			01276nam a2200133Ia 4500
008			220620s9999||||xx |||||||||||||| ||und||
020			_a9783040000000
245		0	_aPolymeric Carriers for Biomedical and Nanomedicine Application
546			_aEnglish[eng]
650			_aosteoarthritis||monosodium iodoacetate||p47phox||PLGA nanoparticles||reactive oxygen species||full factorial design||optimization||metronidazole||nanocomposites||sodium alginate||chitosan||PLGA||hybrid polymers||chitosan-PLGA polymer||NMR||DSC||FT-IR||covalent drug conjugation||therapeutic nanodevice||polymeric nanoparticles||cancer therapy||controlled drug delivery||redox responsive PEG-block-PLA||nanocarriers||disulfide bond||controlled release||retinol||nanosponge||hydrogel||Box–Behnken design||pharmacokinetic||terbinafine hydrogel||niacinamide||polyethene glycol (PEG) 400||solvent||dermal delivery||finite dose||porcine skin||dissolving microneedles||multiple sclerosis||PLP||transdermal delivery||tyrosol||nanoparticles||Design of Experiment (DoE)||β cyclodextrin||DNA binding||glyconanoparticles||immunotherapy||infectious diseases||mannose receptors||nutraceuticals||n/a
700			_aLima, Sofia||Reis, Salette
856			_uhttps://mdpi.com/books/pdfview/book/3857
942			_cEB
999			_c23274 _d23274